<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Oral Dosage Form New Animal Drugs; Pergolide</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Oral Dosage Form New Animal Drugs; Pergolide</h1>
    <p class="timestamp">Published: 2012-03-19 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an original new animal drug application (NADA) filed by Boehringer Ingelheim Vetmedica, Inc. The NADA provides for the veterinary prescription use of pergolide mesylate tablets in horses for the control of clinical signs associated with Pituitary Pars Intermedia Dysfunction (Equine Cushing's Disease).</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Rule</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2012-6544</p>
    <p><strong>Publication Date:</strong> 2012-03-19</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2012/03/19/2012-6544/oral-dosage-form-new-animal-drugs-pergolide">https://www.federalregister.gov/documents/2012/03/19/2012-6544/oral-dosage-form-new-animal-drugs-pergolide</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2012-6544</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
